CorInnova, Inc

Johnson & Johnson Innovation JLABS @ TMC, Houston. With a lead investment from the UK-based Wellcome Trust, a premier international medical foundation, CorInnova is developing a non-blood contacting cardiac assist device. CorInnovas device is a transformative biventricular device to treat acute heart failure. The technology will create a new paradigm for treatment. The device is designed to eliminate adverse events associated with existing cardiac assist technologies, and to expand eligible patients. The device may reverse the progression of HF, a blockbuster application. The device deploys minimally invasively into the pericardial sac in under 30 seconds, and has shown the ability...

Heart failure,minimally invasive,biventricular cardiac assist device,non-blood contacting,cardiovascular,congestive heart failure,medical device,active implantable medical device,cardiac assist,heart assist,soft robotics,mechanical circulatory support (mcs),and cardiac assist

Corinnova, inc operates in the Medical equipment manufacturing industry.

Corinnova, inc's revenue is 11m - 100m

Corinnova, inc has 11 - 50 employees.